NEOPHARM PHARMACANN INVESTORS II, LLC

New Filing
CIK: 0001698261·Investing·DELAWARE·Filed: Mar 9, 2017
Total Offering

$20,000,000

Amount Sold

$3,550,000

Investors

16

First Sale

Feb 28, 2017

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Limited Liability Company
Year Incorporated
2016
Non-Accredited Investors
No

Related Persons

NameRole
Joseph Flanagan
Related Person
Brad Leshnock
Related Person
James Flanigan, Jr.
Related Person
James Patrick Barry
Related Person
John Wagner
Related Person

Company

NEOPHARM PHARMACANN INVESTORS II, LLC

300 SOUTH WACKER DRIVE

CHICAGO, IL, 60606

312-444-6361

SEC Filing

0001698261-17-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
NEOPHARM PHARMACANN INVESTORS II, LLC Form D Filing — $20,000,000 | FilingFlow